Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma

Name: Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma
License: Public Domain

First Affiliated Hospital of Zhejiang University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

immunotherapy

lung squamous cell carcinoma, neoadjuvant therapy, immunotherapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 180376
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.